Tao Mi

机构：Qilu University of Technology, Wuhan University, China International Science and Technology Cooperation, Zhongnan Hospital of Wuhan University, National Clinical Research, Changchun University of Chinese Medicine, Children's Hospital of Chongqing Medical University, Chongqing Medical University · ORCID：0000-0002-5244-1479

发表论文 86 篇 · 总被引 1101 次 · h-index 17

代表论文

• Inducing disulfidptosis in tumors:potential pathways and significance (2024 · MedComm · 被引 28)
• Human Mesenchymal Stem Cells-Derived Exosome Mimetic Vesicles Regulation of the MAPK Pathway and ROS Levels Inhibits Glucocorticoid-Induced Apoptosis in Osteoblasts (2023 · Stem Cells International · 被引 17)
• Dual roles of HK3 in regulating the network between tumor cells and tumor-associated macrophages in neuroblastoma (2024 · Cancer Immunology Immunotherapy · 被引 16)
• Toll-Like Receptor 9 Aggravates Pulmonary Fibrosis by Promoting NLRP3-Mediated Pyroptosis of Alveolar Epithelial Cells (2024 · Inflammation · 被引 16)
• The PI3K-AKT-mTOR signaling pathway mediates the cytoskeletal remodeling and epithelial-mesenchymal transition in bladder outlet obstruction (2023 · Heliyon · 被引 12)
• Uncovering key markers and therapeutic targets for renal fibrosis in diabetic kidney disease through bulk and single-cell RNA sequencing (2025 · Journal of Translational Medicine · 被引 11)